Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 48,736 shares at $19.50 ($969K) on 2016-09-06, disclosed to the SEC on 2016-09-07.
Open-market sale of $969k CLCD by Head, Business Development and Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 3,735 | $73K | 7.5% |
| 2 | $19.50 | 8,549 | $167K | 17.2% |
| 3 | $20.00 | 5,032 | $101K | 10.4% |
| 4 | $20.00 | 31,420 | $628K | 64.9% |
| Total | $19.87 avg | 48,736 | $969K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-07 | $53K | — | Filing → |
| CLCD | SELL | 2016-11-01 | $22K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $96K | — | Filing → |